
An outdated remedy for gout has made a breakthrough in cardiology. Scientists conducted extensive work, combining information from 12 clinical trials involving about 23 thousand patients. The analysis showed that for every thousand people who took the drug, there were eight fewer heart attacks and nine fewer strokes compared to the control group. As for safety, no significant adverse events were recorded, and mild digestive disorders in some patients resolved on their own without medical intervention.